{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:42:15Z","timestamp":1770813735182,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2004,1,23]],"date-time":"2004-01-23T00:00:00Z","timestamp":1074816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1038\/sj.eye.6701315","type":"journal-article","created":{"date-parts":[[2004,1,23]],"date-time":"2004-01-23T10:45:49Z","timestamp":1074854749000},"page":"760-762","source":"Crossref","is-referenced-by-count":49,"title":["Periorbital Oedema and epiphora as ocular side effects of imatinib Mesylate (Gleevec)"],"prefix":"10.1038","volume":"18","author":[{"given":"B","family":"Esmaeli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Diba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H G","family":"Saadati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M M","family":"Faustina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T R","family":"Shepler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Talpaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Fraunfelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M B","family":"Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,1,23]]},"reference":[{"key":"BF6701315_CR1","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with Philadelphia chromosome. N Engl J Med 2001; 344: 1038\u20131042.","journal-title":"N Engl J Med"},{"key":"BF6701315_CR2","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Talpaz M, Resta Debra J, Peng B, Buchdunger E, Ford JM et al. Efficacy and safety of a specific inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia. N Engl J Med 2001; 344: 1031\u20131037.","journal-title":"N Engl J Med"},{"key":"BF6701315_CR3","first-page":"925","volume":"6","author":"MC Heinrich","year":"2000","unstructured":"Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA, Zigler AJ . Inhibition of c-kit receptor tyrosine kinase activity by STI571: targeting BCR-ABL as therapy for CML. Oncologist 2000; 6: 925\u2013932.","journal-title":"Oncologist"},{"key":"BF6701315_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1634\/theoncologist.6-3-233","volume":"6","author":"MJ Mauro","year":"2001","unstructured":"Mauro MJ, Druker BJ . STI571: Targeting BCR-ABL as Therapy for CML. Oncologist 2001; 6: 233\u2013238.","journal-title":"Oncologist"},{"key":"BF6701315_CR5","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/S0140-6736(01)06535-7","volume":"358","author":"AT Van Oosterom","year":"2001","unstructured":"Van Oosterom AT, Judson I, Verweij J, Stroobants S, Di Paulo ED, Dimitrijevic S et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumors: a phase I study. Lancet 2001; 358: 1421\u20131423.","journal-title":"Lancet"},{"key":"BF6701315_CR6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1056\/NEJMoa020461","volume":"347","author":"GD Demeetri","year":"2002","unstructured":"Demeetri GD, von Mehren M, Blanke CD, Van Den Abbeele AD, Eisenberg B, Roberts PJ et al. Efficacy and Safety of Imatinib Mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347: 472\u2013480.","journal-title":"N Engl J Med"},{"key":"BF6701315_CR7","first-page":"2914","volume":"164","author":"HC Hasselbalch","year":"2002","unstructured":"Hasselbalch HC . STI571 (Gleevec), a new drug for the treatment of chronic myeloid leukemia. Ugeskr Laeger 2002; 164: 2914\u20132917.","journal-title":"Ugeskr Laeger"},{"key":"BF6701315_CR8","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/cncr.10729","volume":"95","author":"B Esmaeli","year":"2002","unstructured":"Esmaeli B, Prieto VG, Butler CE, Kim SK, Ahmadi MA, Kantarjian HM et al. Severe periorbital edema secondary to ST1571 (Gleevec). Cancer 2002; 95: 881\u2013887.","journal-title":"Cancer"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6701315.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701315","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701315.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:15:48Z","timestamp":1684412148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6701315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,23]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["BF6701315"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6701315","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,23]]}}}